Editors for Cancer Biology

We aim to publish conceptually important advances in all areas of cancer biology, including the discovery of new mechanisms responsible for cancer initiation, progression and therapy response. We are also interested in clinical trials or other clinical observations that reveal new and important biological insights. Read the latest research in this subject area.

Senior editors

  1. Utpal Banerjee

    University of California, Los Angeles, United States

    Utpal Banerjee is the Irving and Jean Stone Professor and Chair of the Department of Molecular, Cell and Developmental Biology at the University of California, Los Angeles, with a joint appointment in the Department of Biological Chemistry at the David Geffen School of Medicine. He also serves as Co-Director of the Broad Stem Cell Research Center and as Director of the UCLA Interdepartmental Minor in Biomedical Research. He is a member of UCLA’s Jonsson Comprehensive Cancer Center and is affiliated with the Brain Research Institute and the Neuroscience Graduate Program.

    Banerjee’s laboratory has worked on several oncogenic and metabolic signals that are important in development and disease. The lab studies the effects of systemic signals on the maintenance of blood progenitors in Drosophila, and the role of metabolic pathways in the control of proliferation and differentiation in the preimplantation mouse embryo.

    Expertise
    Developmental Biology
    Stem Cells and Regenerative Medicine
    Cancer Biology
    Research focus
    haematopoiesis
    cancer biology
    Experimental organism
    D. melanogaster
    mouse
  2. Wafik S El-Deiry

    Brown University, United States

    Wafik El-Deiry, MD, PhD, FACP is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director, Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown and Lifespan. He is a Professor of Pathology and Laboratory Medicine, Professor of Medical Science, and Mencoff Family University Professor at Brown. He sees patients in his weekly clinic at Rhode Island Hospital focused on care of patients with colorectal cancer and participates in clinical trials based on his laboratory’s research on novel therapeutics. He previously served as Deputy Director for Translational Research, co-Leader of the Molecular Therapeutics Program, Professor of Oncology, and the William Wikoff Smith Endowed Chair in Cancer Research at Fox Chase Cancer Center. From 2010 through 2014 Dr El-Deiry was the Rose Dunlap Professor of Medicine and Chief of Hematology-Oncology at Penn State. In 2009, El-Deiry became an American Cancer Society Research Professor. He was previously a tenured Professor of Medicine (Hematology-Oncology), Genetics, and Pharmacology at University of Pennsylvania, co-Leader of the Radiobiology and Imaging Program at the Abramson Cancer Center and Associate Director for Physician-Scientist Training in Hematology-Oncology when he left Penn in 2010. He earned MD/PhD degrees from University of Miami School of Medicine and completed internal medicine residency and medical oncology fellowship at the Johns Hopkins Hospital and the Johns Hopkins Oncology Center. As a practicing academic Oncologist, his scientific interest and expertise is in cell death, drug resistance in cancer and drug discovery and development. El-Deiry founded two companies, Oncoceutics, Inc. and p53-Therapeutics, Inc.

    El-Deiry discovered p21(WAF1) as a p53 target gene, universal cell cycle inhibitor, and tumor suppressor gene that for the first time explained the mammalian cell stress response. He discovered TRAIL receptor DR5 and its regulation by p53. TRAIL is part of the host immune system that suppresses cancer and its metastases. His lab created a knock-out mouse for TRAIL receptor DR5 and this mouse is tumor prone and develops an inflammatory syndrome in the lungs and gut after sub-lethal irradiation. He identified c-Myc as a major determinant of TRAIL sensitivity and demonstrated synergy between TRAIL therapy and multi-kinase inhibitor sorafenib. Building on his prior accomplishments, El-Deiry discovered ONC201/TIC10 as a first-in-class TRAIL pathway inducer that is orally bioavailable and crosses the blood-brain barrier to treat brain tumors. TRAIL and Foxo3a are required for the anti-tumor effect of ONC201 through dual blockade of ERK and Akt kinases that promotes the nuclear translocation of the Foxo3a transcription factor which directly regulates the TRAIL gene. Data from El-Deiry’s lab identified that ONC201 induces TRAIL receptor DR5 through an integrated stress response involving ATF4 and CHOP transcription factors. Patients with among the most aggressive gliomas (H3K27M mutant DIPG) have had exceptional responses to ONC201.

    As a physician-scientist, Dr El-Deiry has worked to bring new discoveries to the clinic. He is committed in the next phase of his career to unraveling the mechanisms involved in p53 pathway restoration by candidate therapeutics his lab has discovered. This is exciting as he is defining a novel class of anti-cancer drugs with p53 pathway restoration and S-phase checkpoint targeting and recognizing ATF4 as a major transcription factor mechanism for p53 pathway restoration in p53-null or p53 mutant tumor cells. He is establishing transcriptomic and proteomic data sets with chemotherapy that acts through p53, and with novel small molecules that restore the p53 pathway in p53-deficient or mutant p53 expressing cells. He is exploiting medicinal chemistry and organoid technologies to perform his translational science that is leading to clinical trials some of which he leads. Dr El-Deiry conducts basic and translational clinical oncology therapeutics research through funded NIH grants, Foundations and industry. He is a member of the ASCI, AAP, Past President of the Interurban Clinical Club, previous Chair of ASCO’s Tumor Biology Track, and past Chair of an NIH Study Section on Cancer Therapeutics. Dr El-Deiry has trained many students and post-doctoral fellows, physician-scientists, and continues to mentor junior scientists and faculty in basic and translational cancer research.

    Expertise
    Medicine
    Cancer Biology
    Research focus
    cancer
    tumor suppressor genes
    colorectal cancer
    p53 pathway
    cell death
    medical oncology
    drug development
    drug discovery
    p21(WAF1)
    ONC201/TIC10
    physician-scientist issues
    Experimental organism
    human
    mouse
    Competing interests statement
    Dr El-Deiry receives funding from the NIH/NCI, the Warren Alpert Foundation, and D&D Pharmatech. He is a Specialty Chief Editor for the Cancer Molecular Targets and Therapeutics Section of Frontiers in Oncology. He is also a Section Editor for Molecular Oncology and HemOnc Today. Dr El-Deiry is the scientific founder and shareholder of Oncoceutics, Inc.
    and p53-Therapeutics, Inc.
  3. Eduardo Franco

    McGill University, Canada

    Eduardo Franco is Professor and Chairman, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal. He holds BSc (1975) and Licentiate (1976) degrees in biology from Universidade de Campinas, Brazil, and master's (MPH) and doctoral (DrPH) degrees in public health microbiology from the University of North Carolina at Chapel Hill (1981-84). He was a Guest Researcher at the US Centers for Disease Control in Atlanta (1980-81 and 1983-84), and a post-doctoral fellow in cancer epidemiology during 1984 at the International Agency for Research on Cancer in Lyon, France, at the US National Cancer Institute (NCI) in Bethesda, and at Louisiana State University, in New Orleans. Since 1985, he has conducted epidemiologic research on the causes of cancer and on the means to prevent it or to improve patient survival. He is mostly known for his contributions to our understanding of human papillomavirus infection as the cause of cervical cancer and using this knowledge to prevent this cancer via vaccination and improved screening strategies. He received the Canadian Cancer Research Alliance’s Distinguished Service to Cancer Research Award, Lifetime Achievement Awards from the American Society for Colposcopy and Cervical Pathology and from the International Papillomavirus Society, the Women in US Government’s Leadership Award, the Canadian Cancer Society’s Warwick Prize, the Geoffrey Howe Outstanding Contribution Award from the Canadian Society for Epidemiology and Biostatistics, the University of British Columbia’s Chew Wei Memorial Prize in Cancer Research, and the McLaughlin-Gallie Award from the Royal College of Physicians of Canada. He has mentored 115 graduate students and post-doctoral fellows, and 30 undergraduate trainees. He is Officer of the Order of Canada and Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. Heholds an honorary doctorate from Universidade Fernando Pessoa, Porto, Portugal.

    Expertise
    Cancer Biology
    Epidemiology and Global Health
    Medicine
    Research focus
    cancer epidemiology
    cancer prevention
    human papillomavirus
    cancer screening
    Experimental organism
    human
    Competing interests statement
    Entire research program funded by the Medical Research Council of Canada (until 1999), Canadian Institutes of Health Research (CIHR) (1999-present), National Institutes of Health, Canadian Cancer Society, and Cancer Research Society. He has received salary awards from the Fonds de Recherche Quebec Santé and CIHR. He holds a James McGill Professorship and the Minda de Gunzburg Endowed Chair at McGill University. He serves as Editor-in-Chief for Preventive Medicine and Preventive Medicine Reports and serves on the editorial boards of Cancer Epidemiology, Biomarkers & Prevention, International Journal of Cancer, Papillomavirus Research, and Salud Publica de Mexico. He has served as occasional consultant to companies involved with HPV vaccination (Merck and GSK) and HPV diagnostics (Roche, Abbott, Qiagen, and BD).
  4. Erica Golemis

    Fox Chase Cancer Center, United States

    Erica A Golemis, PhD is a Professor at Fox Chase Cancer Center (FCCC), and Adjunct Professor at the Temple University School of Medicine, the University of Pennsylvania, and the Drexel University College of Medicine. Since 2008, she has served as Co-Leader for the FCCC Molecular Therapeutics program, and as Deputy Chief Science Officer at FCCC. She is an elected Fellow of the American Association for the Advancement of Science, and holds the William Wikoff Smith Chair in Biology at Fox Chase. Dr Golemis joined FCCC in 1993, after completing graduate training in mechanisms of leukemogenesis at MIT, and postdoctoral work at Harvard Medical School and Massachusetts General Hospital leading to the development of new technology for the identification and analysis of protein interaction networks. One focus of her reserch is the targeted study of a group of oncogenes including NEDD9, AURKA, and associated proteins that regulate cell cycle and metastasis; this work has recently focused on defining non-canonical activities of these proteins in control of ciliation as a mechanism for their oncogenic effect. A second research area is the use of bioinformatics-guided and siRNA screening approaches to elucidate signaling networks that can be targeted to improve therapeutic response; this work is typically highly collaborative with clinical researchers. In the past 25 years, she has served continuously on peer-review panels for the NIH, the American Cancer Society, the DOD, the Komen Foundation, and other agencies.

    Expertise
    Cancer Biology
    Cell Biology
    Research focus
    signal transduction
    targeted therapy
    mitosis
    cilia
    polycystic kidney disease
    colorectal cancer
    head and neck cancer
    invasion
    metastasis
    Competing interests statement
    Dr Golemis currently receives funding from the National Institutes of Health (NIH) and holds editorial roles at the following journals: Cancer Biology and Therapy, Frontiers in Oncology, Gene and BMC Cancer.
  5. Maureen Murphy

    The Wistar Institute, United States

    Maureen E. Murphy, Ph.D., is a Professor and Program Leader in the Molecular and Cellular Oncogenesis Program of The Wistar Institute. Dr. Murphy joined Wistar in 2011 and became a Program Leader in early 2012. She is also an adjunct professor at Drexel University College of Medicine and The Perelman School of Medicine at the University of Pennsylvania. Previously, Dr. Murphy was a professor at the Fox Chase Cancer Center. Since 1999, she has received continuous support from the National Cancer Institute (NCI) for her research on the p53 tumor suppressor protein and the HSP70 molecular chaperone.

    A noted expert in the role of the p53 gene in cancer, Dr. Murphy’s laboratory focuses on how p53 functions to suppress tumor development. Through her lab’s work, Dr. Murphy is investigating the genetics of cancer health disparities. In efforts to improve precision medicine, her group is performing drug screens on tumor cells containing this variant, with the goal of finding drugs that will kill these cells preferentially. For her work on p53, Dr. Murphy is the recipient of the 2016 Gateway for Cancer Research Leadership in Cancer Advocacy Award. Murphy’s group also studies the stress-induced protein HSP70. With the knowledge that HSP70 is overexpressed in late stage cancers, Dr. Murphy’s group has pioneered the use of inhibitors of HSP70 for cancer therapy, particularly metastatic melanoma. For this effort, in 2014 her group won a Discovery Fast Track award from GlaxoSmithKline for the development of HSP70 inhibitors for cancer therapy.

    In addition to her research, Dr. Murphy also plays pivotal administrative roles as Wistar’s Associate Vice President for Faculty Affairs, the Principal Investigator of its Training Grant in Basic Cancer Research, the head of the Junior Faulty Mentoring program, and the Director of its Postdoctoral Training Program. A member of the NCI’s Cancer and Molecular Pathology (CAMP) federal grant review committee, Dr. Murphy has also reviewed grants for the New Jersey Commission for Cancer Research, the Department of Defense, and Alex’s Lemonade Stand Foundation for Pediatric Cancer Research.

    Dr. Murphy earned a Bachelor of Science degree in biochemistry at Rutgers University, followed by a doctorate in molecular biology at the University of Pennsylvania School of Medicine. In 1994, she began postdoctoral research at Princeton University in the laboratory of Arnold J. Levine, Ph.D., a co-discoverer of p53 and a pioneer in the field of tumor suppressor genes and cancer biology.

    Expertise
    Cancer Biology
    Research focus
    p53
    ferroptosis
    mitochondria
    colon cancer
    HSP70
    polymorphism
    Competing interests statement
    Maureen Murphy is a member of the American Association for Cancer Research (AACR). In addition to eLife, she holds editorial positions at Cancer Biology and Therapy (Senior Editor), Cancer Research (Senior Editor), Molecular Cancer Research and Carcinogenesis Integrative Research. She is a member of the NIH NCI Cancer and Molecular Pathology federal grant review committee, and receives federal funding from the National Institutes of Health (NIH).
  6. Päivi Ojala

    University of Helsinki, Finland
    Imperial College London, United Kingdom

    Päivi Ojala is the Professor of Cancer Cell Biology at University of Helsinki and Chair of Viral Tumorigenesis at Imperial College London. She has made significant contributions to the Kaposi’s Sarcoma herpesvirus (KSHV) field and has more recently focused also on the role of lymphatic endothelial microenvironment on cancer cell metastasis. She has expertise in organotypic 3D co-culture models, cell-based high-content screens, protein kinase signalling and viral technologies. Her work has led to demonstration of restoration of p53 function by small molecule inhibitors as a therapeutic modality for KSHV-induced lymphomas, identification of host Pim kinases, nucleophosmin, and the p53-p21 axis as novel regulators of viral replication, and shown that KSHV infection reprograms lymphatic endothelial cells (LECs) to a new, more invasive cell type. They have also demonstrated that LEC interaction with melanoma cells leads to increased distant organ metastasis in vivo, which is dependent on MMP14, Notch3 and b1-integrin- Dr. Ojala holds a doctoral degree in Molecular Genetics from the University of Helsinki, and has received postdoctoral training at the Yale School of Medicine, CT, USA.

    Expertise
    Cancer Biology
    Microbiology and Infectious Disease
    Research focus
    human tumor viruses
    virus-host interactions
    tumor microenvironment
    metastasis
    Competing interests statement
    Päivi Ojala receives funding from the Academy of Finland, Sigrid Juselius Foundation, Cancer Foundation Finland and University of Helsinki.
  7. Richard M White

    Memorial Sloan Kettering Cancer Center, United States

    Richard White, M.D., Ph.D, is a physician-scientist at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. He is interested in basic mechanisms underlying metastasis, using the zebrafish as a model system. His work has established numerous techniques for cancer modeling and high-resolution imaging in the fish. Using these tools, the lab is focused on the cross-talk between tumor cells and the microenvironment, and how this interplay influences metastatic success. His work has revealed novel interactions between melanoma cells and adipocytes in the microenvironment, and how neural crest programs play roles in melanoma progression. He has been awarded the NIH Director’s New Innovator Award, the Pershing Square Foundation Award, and the Mark Foundation ASPIRE award.

    Expertise
    Cancer Biology
    Medicine
    Research focus
    metastasis
    melanocyte development
    neural crest
    melanoma
    adipocytes
    microenvironment
    melanocytes
    Experimental organism
    zebrafish
    Competing interests statement
    Richard White receives funding from the National Institutes of Health, the Pershing Square Sohn Foundation, the Mark Foundation, the Melanoma Research Alliance, the American Cancer Society and the Harry J. Lloyd Foundation. He receives consulting fees from N-of-One, Inc.

Reviewing editors

  1. Nicholas Banovich

    Translational Genomics Research Institute (TGen), United States

    Expertise
    Cancer Biology
    Genetics and Genomics
    Chromosomes and Gene Expression
    Research focus
    single cell biology
    CAR T cell therapy
    gene regulation
    pulmonary fibrosis
    quantitative trait loci
  2. Frederic A Bard

    Institute of Molecular and Cell Biology (A*STAR), Singapore

    Expertise
    Cell Biology
    Cancer Biology
    Research focus
    Golgi
    protein glycosylation
    signaling
    cancer
    matrix degradation
    cell migration
    Experimental organism
    human
    mouse
  3. Xuetao Cao

    Zhejiang University School of Medicine, China

    Expertise
    Cancer Biology
    Immunology and Inflammation
    Medicine
    Research focus
    immunology of APCs
    TLR signalling and immune regulation
    cancer immunotherapy and gene therapy
  4. Vincenzo Cerullo

    University of Helsinki, Finland

    Expertise
    Cancer Biology
    Immunology and Inflammation
    Research focus
    oncolytic viruses
    cancer vaccines
    vaccines
    tumor antigens
    Experimental organism
    human
    mouse
  5. Nyasha Chambwe

    St Jude Children's Research Hospital, United States

    Expertise
    Cancer Biology
    Computational and Systems Biology
    Genetics and Genomics
    Research focus
    bioinformatics
    computational biology
    cancer genomics
    population genomics
    data analysis
    Experimental organism
    human
  6. Seth J Corey

    Cleveland Clinic, United States

    Expertise
    Cancer Biology
    Medicine
    Research focus
    myeloid malignancies
    inherited or acquired bone marrow failure
    neutrophils
    platelets zebrafish
    cancer evolution
    proteostasis
  7. Edna Cukierman

    Fox Chase Cancer Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Research focus
    tumor microenvironment
    fibroblastic cells
    cancer associated fibroblasts
    extracellular matrix fibrillogenesis
    extracellular matrix function
    wound healing
    fibrosis
    cancer triad
    fibroblastic cell function
    stromagenesis
    desmoplasia
    pancreatic cancer
    epithelial cancers
  8. Irwin Davidson

    Institut de Genetique et de Biologie Moleculaire et Cellulaire, CNRS/INSERM/UDS, France

    Expertise
    Biochemistry and Chemical Biology
    Cancer Biology
    Chromosomes and Gene Expression
    Research focus
    transcription
    chromatin
    genomics
    cancer
    Experimental organism
    human
    mouse
  9. Roger J Davis

    University of Massachusetts Medical School, United States

    Expertise
    Biochemistry and Chemical Biology
    Cancer Biology
    Cell Biology
    Research focus
    diabetes
    NAFLD
    NASH
    metabolism
    insulin resistance
    cancer
    signal transduction
    Experimental organism
    mouse
    human
  10. Ralph J DeBerardinis

    University of Texas Southwestern Medical Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Medicine
    Research focus
    metabolism
    cancer
    genetics
    medicine
    pediatrics
    genomics
    mitochondria
    Experimental organism
    human
    mouse
  11. Elisabetta Dejana

    FIRC Institute of Molecular Oncology, Italy

    Expertise
    Cancer Biology
    Cell Biology
    Developmental Biology
    Research focus
    angiogenesis
    cell adhesion
    VE-cadherin
    vascular permeability
    vascular development and patterning
    endothelium
    blood brain barrier
    Experimental organism
    mouse
  12. Martin Eilers

    University of Würzburg, Germany

    Expertise
    Cancer Biology
    Research focus
    Myc proteins
    Myc function
    Targeting N-MYC/AURORA for tumor therapy
    Myc and Ubiquitin
    Experimental organism
    human
  13. Joaquin Espinosa

    University of Colorado Anschutz Medical Campus, United States

    Expertise
    Cancer Biology
    Cell Biology
    Research focus
    cancer biology
    apoptosis
    p53
    tumor suppressors
    trisomy 21
    Down syndrome
    gene expression
    chromatin
  14. Eduardo Eyras

    Australian National University, Australia

    Expertise
    Genetics and Genomics
    Cancer Biology
    Chromosomes and Gene Expression
    Computational and Systems Biology
    Research focus
    bioinformatics
    transcriptomics
    long-read sequencing technologies
    RNA splicing
    alternative splicing
    nanopore
  15. Lydia W S Finley

    Memorial Sloan Kettering Cancer Center, United States

    Expertise
    Cell Biology
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Research focus
    cell metabolism
    cancer
    stem cells
    epigenetics
    cell fate
  16. Margaret Frame

    University of Edinburgh, United Kingdom

    Expertise
    Cancer Biology
    Research focus
    cancer
    cell adhesion networks
    nodal tyrosine kinases
  17. Michael R Green

    University of Massachusetts Medical School, United States

    Expertise
    Cancer Biology
    Chromosomes and Gene Expression
    Medicine
    Research focus
    transcription
    pre-mRNA splicing
    cancer molecular biology
    oncology
    genetics
    functional genomics
    Experimental organism
    human
    mouse
    S. cerevisiae
  18. William C Hahn

    Dana-Farber Cancer Institute, United States

    Expertise
    Cancer Biology
    Genetics and Genomics
    Medicine
    Research focus
    cancer
    transformation
    functional genomics
    RAS
    YAP1
    Experimental organism
    human
  19. Matthew G. Vander Heiden

    Massachusetts Institute of Technology, United States

    Expertise
    Cancer Biology
    Medicine
    Research focus
    cancer biology
    biochemistry
    metabolism
    tumor microenvironment
    redox biology
    Experimental organism
    mouse
    human
  20. Wenwei Hu

    Rutgers University, United States

    Expertise
    Cancer Biology
    Research focus
    p53 signaling
    tumor suppressors
    cancer metabolism
    cancer cell biology
    signal transduction
    Experimental organism
    human
    mouse
  21. Tony Hunter

    Salk Institute for Biological Studies, United States

    Expertise
    Cancer Biology
    Cell Biology
    Research focus
    cancer
    signal transduction
    phosphorylation
    ubiquitylation
    sumoylation
    Experimental organism
    mouse
    yeast
  22. Arezu Jahani-Asl

    McGill University, Canada

    Expertise
    Cancer Biology
    Cell Biology
    Developmental Biology
    Research focus
    glioblastoma
    stem cells
    mitochondria
    transcription
    mental retardation
    neurodegeneration
    cancer
    Experimental organism
    mouse
  23. Gou Young Koh

    Institute of Basic Science and Korea Advanced Institute of Science and Technology (KAIST), South Korea

    Expertise
    Cancer Biology
    Developmental Biology
    Research focus
    angiogenesis
    lymphangiogenesis
    adipogenesis
    cardiogenesis
    vascular and cardiovascular biology
  24. Ashish Lal

    National Institutes of Health, United States

    Expertise
    Cancer Biology
    Biochemistry and Chemical Biology
    Chromosomes and Gene Expression
    Genetics and Genomics
    Research focus
    RNA biology
    lncRNAs
    microRNAs
    gene regulation
    cancer biology
    p53
    Experimental organism
    human
  25. Beate Lichtenberger

    Medical University of Vienna, Austria

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Research focus
    Cancer-associated fibroblasts (CAFs)
    fibroblast-mediated skin pathologies
    skin cancer
    stem cell fate decisions
    Experimental organism
    human
    mouse
  26. Yuting Ma

    Suzhou Institute of Systems Medicine, China

    Expertise
    Cancer Biology
    Immunology and Inflammation
    Cell Biology
    Research focus
    tumor immunology
    immunotherapy
    tumor microenvironment
    stress responses
    neuroendocrine-immune crosstalk
    cell death
  27. Kay F Macleod

    University of Chicago, United States

    Expertise
    Cell Biology
    Cancer Biology
    Research focus
    autophagy
    mitochondria
    pancreatic cancer
    breast cancer
    liver homeostasis
    tumor metabolism
    Experimental organism
    mouse
    human
  28. Jean-Christophe Marine

    Vlaams Instituut voor Biotechnologie, Belgium

    Expertise
    Cancer Biology
    Genetics and Genomics
    Research focus
    mouse genetics
    molecular oncology
    cancer genomics
    Experimental organism
    mouse
  29. Grant McArthur

    Peter MacCallum Cancer Centre, Australia

    Expertise
    Cancer Biology
    Medicine
    Research focus
    melanoma
  30. Martin McMahon

    University of Utah, United States

    Expertise
    Cancer Biology
    Research focus
    mouse models
    signal transduction
    RAS
    BRAF
    PI3-kinase
    Experimental organism
    mouse
  31. Goutham Narla

    University of Michigan, United States

    Expertise
    Medicine
    Cancer Biology
    Genetics and Genomics
    Research focus
    cancer therapeutics
    cancer genetics
    small molecule drug development
    protein phosphatase
    Experimental organism
    human
    mouse
  32. Duojia Pan

    UT Southwestern Medical Center, United States

    Expertise
    Cancer Biology
    Cell Biology
    Research focus
    growth control
    tumor suppressors
    oncogenes
    Hippo signaling
    transcription
    regeneration
    Experimental organism
    D. melanogaster
    mouse
  33. Maddy Parsons

    King's College London, United Kingdom

    Expertise
    Biochemistry and Chemical Biology
    Cancer Biology
    Cell Biology
    Physics of Living Systems
    Research focus
    adhesion
    migration
    cytoskeleton
    receptor signalling
    extracellular matrix
    fibrosis
    cancer
    Experimental organism
    mouse
  34. Renata Pasqualini

    Rutgers University, United States

    Expertise
    Medicine
    Cancer Biology
    Research focus
    radiation oncology
    translational cancer research
    prostate cancer
    vascular biology
  35. Lynne-Marie Postovit

    University of Alberta, Canada

    Expertise
    Cancer Biology
    Cell Biology
    Stem Cells and Regenerative Medicine
    Research focus
    cellular plasticity
    tumour microenvironment
    hypoxia
    stem cells
    metastasis
    ovarian cancer
    breast cancer
  36. Daniela Robles-Espinoza

    International Laboratory for Human Genome Research, Mexico

    Expertise
    Cancer Biology
    Genetics and Genomics
    Research focus
    melanoma
    bioinformatics
    telomeres
    acral lentiginous melanoma
    sequencing
  37. Jody Rosenblatt

    King's College London, United Kingdom

    Expertise
    Cell Biology
    Cancer Biology
    Research focus
    apoptosis
    mitosis
    cell extrusion
    epithelial
    homeostasis
    morphogenesis
    cancer cell biology
  38. Charles Sawyers

    Memorial Sloan-Kettering Cancer Center, United States

    Expertise
    Cancer Biology
    Medicine
    Research focus
    translational medicine
    oncology
    Experimental organism
    human
  39. Katharina Schlacher

    UT MD Anderson Cancer Center, United States

    Expertise
    Cancer Biology
    Chromosomes and Gene Expression
    Research focus
    DNA replication
    genome instability
    BRCA2
    p53
    PTEN
    homologous recombination
    DNA repair
  40. Jeffrey Settleman

    Pfizer, United States

    Expertise
    Cancer Biology
    Research focus
    cancer cell biology
    signal transduction
    tumor heterogeneity
    signaling
    epigenetics
  41. Nima Sharifi

    Cleveland Clinic, United States

    Expertise
    Biochemistry and Chemical Biology
    Cancer Biology
    Medicine
    Research focus
    steroid biochemistry
    steroid metabolism
    prostate cancer
    nuclear receptors
    hormone therapy resistance
    androgens
    oncology
    Experimental organism
    mouse
  42. Maria Spies

    University of Iowa, United States

    Expertise
    Biochemistry and Chemical Biology
    Cancer Biology
    Chromosomes and Gene Expression
    Structural Biology and Molecular Biophysics
    Research focus
    single-molecule biophysics
    DNA repair
    DNA replication
    DNA recombination
    genome stability
    protein dynamics
    protein-nucleic acids interactions
    drug discovery
    Experimental organism
    human
    yeast
    bacteria
  43. Margaret Stanley

    University of Cambridge, United Kingdom

    Expertise
    Cancer Biology
    Microbiology and Infectious Disease
    Medicine
    Epidemiology and Global Health
    Research focus
    vaccines
    cervix cancer
    cervix precancer
    keratinocyte biology
    human papillomavirus
    DNA viruses
    vaccine immunology
    Experimental organism
    human
  44. Ivan Topisirovic

    Jewish General Hospital, Canada

    Expertise
    Biochemistry and Chemical Biology
    Cancer Biology
    Cell Biology
    Research focus
    mRNA translation
    signaling
    metabolic regulation
    protein quality control
    Experimental organism
    mouse
    human
  45. Alfonso Valencia

    Barcelona Supercomputing Center, Spain

    Expertise
    Cancer Biology
    Computational and Systems Biology
    Research focus
    bioinformatics
    computational biology
    structural bioinformatics
    co-evolution
    cancer genomics
    text mining
  46. Eric J Wagner

    University of Texas Medical Branch at Galveston, United States

    Expertise
    Chromosomes and Gene Expression
    Biochemistry and Chemical Biology
    Cancer Biology
    Genetics and Genomics
    Research focus
    RNA biology
    transcription
    RNA processing
    gene expression
  47. Jian Xu

    University of Texas Southwestern Medical Center, United States

    Expertise
    Cancer Biology
    Chromosomes and Gene Expression
    Developmental Biology
    Genetics and Genomics
    Stem Cells and Regenerative Medicine
    Research focus
    hematopoiesis
    erythropoiesis
    myeloid leukemia
    epigenetics
    transcription regulation
    enhancer
    metabolism
    Experimental organism
    human
    mouse
  48. Norma Ybarra

    Research Institute McGill University Health Center, Canada

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Research focus
    radiation biology
    radiotherapy
    cancer cell metabolism
    cancer therapies
  49. Hao Zhu

    University of Texas Southwestern Medical Center, United States

    Expertise
    Cancer Biology
    Stem Cells and Regenerative Medicine
    Medicine
    Research focus
    mechanisms of tissue repair and organ regeneration
    liver cancer
    hepatocellular carcinoma
    epigenetics
    polyploidy
    Experimental organism
    human
    mouse
  50. Wilbert Zwart

    Netherlands Cancer Institute, Netherlands

    Expertise
    Cancer Biology
    Medicine
    Research focus
    breast cancer
    prostate cancer
    hormonal regulation
    epigenetics
    transcription factors
    genomic profiling
    Experimental organism
    human